Published in Proteome Sci on July 02, 2007
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05
A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci (2007) 0.92
Quadratic variance models for adaptively preprocessing SELDI-TOF mass spectrometry data. BMC Bioinformatics (2010) 0.81
A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature. Proteome Sci (2008) 0.79
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics (2004) 4.58
Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin Chem Lab Med (2005) 1.68
Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res (2004) 1.63
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem (2005) 1.46
Multifactorial screening design and analysis of SELDI-TOF ProteinChip array optimization experiments. Biotechniques (2003) 1.00
Bioinformatics strategies for proteomic profiling. Clin Biochem (2004) 0.91
Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum. Clin Chem Lab Med (2006) 0.91
Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry. Clin Chim Acta (2005) 0.88
Measurement reproducibility in the early stages of biomarker development. Dis Markers (2004) 0.85
Influence of matrix application timing on spectral reproducibility and quality in SELDI-TOF-MS. Biotechniques (2004) 0.84
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol (2008) 1.93
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection? J Pediatr Gastroenterol Nutr (2003) 1.55
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis (2007) 1.44
Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches. Virus Res (2003) 1.43
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model (2007) 1.18
Melioidosis diagnostic workshop, 2013. Emerg Infect Dis (2015) 1.16
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics (2008) 1.09
Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology (2008) 1.08
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Impaired immune function in Gulf War Illness. BMC Med Genomics (2009) 1.03
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct (2008) 1.00
Impact of RNA extraction from limited samples on microarray results. Biotechniques (2003) 0.95
Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis (2006) 0.94
Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med (Berl) (2004) 0.93
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol (2005) 0.92
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. BMC Genomics (2005) 0.92
A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci (2007) 0.92
Infective endocarditis in northeastern Thailand. Emerg Infect Dis (2014) 0.91
Exploration of neuroendocrine and immune gene expression in peripheral blood mononuclear cells. Brain Res Mol Brain Res (2004) 0.91
Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med (2008) 0.91
Assessment of normal variability in peripheral blood gene expression. Dis Markers (2002) 0.91
Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput Biol (2009) 0.90
Impact of acute psychosocial stress on peripheral blood gene expression pathways in healthy men. Biol Psychol (2009) 0.89
Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics (2006) 0.89
Identification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA. BMC Res Notes (2011) 0.87
Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med (2012) 0.86
A pilot study of immune network remodeling under challenge in Gulf War Illness. Brain Behav Immun (2010) 0.85
Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology (2011) 0.83
Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. Cancer Epidemiol Biomarkers Prev (2007) 0.82
Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication. Arch Pathol Lab Med (2005) 0.82
Exploring the diagnostic potential of immune biomarker coexpression in Gulf War Illness. Methods Mol Biol (2012) 0.82
Exploration of statistical dependence between illness parameters using the entropy correlation coefficient. Pharmacogenomics (2006) 0.81
Global amplification of sense RNA: a novel method to replicate and archive mRNA for gene expression analysis. Genomics (2003) 0.80
Gene expression profiling of dysplastic differentiation in cervical epithelial cells harboring human papillomavirus 16. Genomics (2005) 0.80
Absence of Mycoplasma species DNA in chronic fatigue syndrome. J Med Microbiol (2003) 0.79
Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis. Brain Res (2005) 0.78
Molecular markers for early detection of cervical neoplasia. Dis Markers (2004) 0.77
Comparison of target labeling methods for use with Affymetrix GeneChips. BMC Biotechnol (2007) 0.77
Live sequence charts to model medical information. Theor Biol Med Model (2012) 0.75
Microarray technology for use in molecular epidemiology. Methods Mol Biol (2007) 0.75
Modifying differential display polymerase chain reaction to detect relative changes in gene expression profiles. Anal Biochem (2002) 0.75
Two optimized combination assays to examine apoptosis pathways in clinical samples. Cytometry A (2007) 0.75
Role of global disease detection laboratories in investigations of acute respiratory illness. J Infect Dis (2013) 0.75